Kees Roks is the Head of the European Oncology Business at Novartis.
Since November 2018 he is responsible for leading over 2000 dedicated associates in 51 countries on the journey to reimagine medicines.
His Novartis career started in 1985 in the Netherlands. Since then, he has held various roles of increasing responsibility in several international markets and cultures from Europe to Latin America and Asia.
Each move has given him a greater perspective on why innovation, access, affordability, and accessibility to care are now more critical than ever. Exposure to different cultures enhanced his inclusive leadership style and his passion for mentoring and coaching.
Beyond his professional career, he is a member of the EFPIA Patient Access Committee. He is part of the Assembly of the EU Cancer Mission and a member of the Scientific Advisory Board for the Open Research Europe initiative, both for the European Commission.
Kees studied Medical Microbiology and holds a degree in Business Administration from the University of Eindhoven, Netherlands.